# Hemi Ventures

> Hemi Ventures is a VC fund backing Health Care and Artificial Intelligence. See 33 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Palo Alto, United States
- Total investments: 33
- Last investment: May 2020
- Lead investor: 18%
- Last fund: Sep 2016
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/hemi-ventures/
- Website: http://www.hemi.vc/

Hemi Ventures is a VC fund in Palo Alto focused on Health Care and Artificial Intelligence. Hemi Ventures invests in early stage startups in autonomous vehicles, artificial intelligence applications, biotech, and other emerging technology sectors. We partner with entrepreneurs whose cutting edge innovations unlock new frontiers for human potential. ‘Hemi’ (hēmi-) means ‘half’ in Greek. We serve as a complementary half to our founders. Inaddition to capital, we help founders establish pivotal relationships with industry partners and customers to build strong ecosystems that help them grow.

## Contacts

5 contacts available for Hemi Ventures. Shizune tracks 2 team members at Hemi Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hemi-vc?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $500k–$6M |
| Series A | $2M–$31M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 21% |
| Artificial Intelligence | 7 | 21% |
| Automotive | 6 | 18% |
| Biotechnology | 6 | 18% |
| Autonomous Vehicles | 5 | 15% |

48 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 15 | 45% |
| Series A | 11 | 33% |
| Funding Round | 3 | 9% |
| Pre-Seed | 1 | 3% |
| Convertible Note | 1 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 22 | 67% |
| China | 1 | 3% |
| South Korea | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Amy Gu | Founder and Managing Partner | 6 | https://shizune.co/investors/profile/amy-gu |
| Justin Li | Principal | 0 | https://shizune.co/investors/profile/zhenglin-li |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Novauto | Novauto develops an intelligent computing platform for smart driving. |  | Series A | May 14, 2020 |  |
| Phase Genomics | Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology. |  | Venture - Series Unknown | Feb 26, 2020 |  |
| Ravel Biotechnology | Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA.The technology platform enables the accelerated development and validation of screening tests for a wide range of diseases from a single analyte, cell-free DNA. Thus providing the opportunity to screen for a multitude of diseasesfrom a single blood draw.The company was co-founded by Erik Gafni and Nathan Boley in 2018 and is based in San Francisco, California. |  |  | Jan 01, 2020 |  |
| Heroic-Faith Medical Science | Elaborate the cutting edge electronic technology and the most advanced medical science to equip the clinicians |  | Series A | Dec 09, 2019 |  |
| X-37 | X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc. to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets. | $14.5M | Series A | Nov 14, 2019 |  |
| Smart Radar System | Smart Radar System (SRS) is a pioneer in the field of 4D image radar. Having specialized in radar technology for more than three years, SRS is developing the world's first 4D image radar, RETINA, with sub 1 degree angular resolution and 360 degree surround view. | $4M | Series A | Oct 28, 2019 |  |
| metaMe Health | MetaMe Health is currently developing Regulora™ for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora™ for IBS provides relief bydigitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms. |  | Seed | Aug 05, 2019 |  |
| Tensorflight | Tensorflight provides detailed, accurate, and near-instant commercial property data. Our engine based on machine learning, AI, and computer vision analyzes images of the whole structure in order to build a database of all buildings in the world, providing features such as:- Building footprint and square footage- AI-based replacement cost-Number of stories- Construction type- Roof attributes like geometry or material- And much more | $2M | Series A | Jul 17, 2019 |  |
| Tensorflight | Tensorflight provides detailed, accurate, and near-instant commercial property data. Our engine based on machine learning, AI, and computer vision analyzes images of the whole structure in order to build a database of all buildings in the world, providing features such as:- Building footprint and square footage- AI-based replacement cost-Number of stories- Construction type- Roof attributes like geometry or material- And much more | $2M | Seed | Jul 17, 2019 |  |
| NAVAN Technologies | NAVAN Technologies, Inc., (NAVAN) is a pre-clinical stage biotechnology company developing and commercializing its proprietary NanoStraw platform technology, which establishes a direct, physical connection into cells to overcome a huge challenge faced by researchers globally: delivering material into hard-to-transfect-cells in an efficient yetgentle and non-perturbative manne |  | Seed | Apr 25, 2019 |  |

10 of 33 investments shown.

## Co-investors
- [Mandra Capital](https://shizune.co/investors/profile/mandra-capital) — VC Fund, 4 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 3 deals together
- [ff Venture Capital](https://shizune.co/investors/profile/ff-venture-capital) — VC Fund, 2 deals together
- [GMO VenturePartners](https://shizune.co/investors/profile/gmo-venturepartners) — VC Fund, 2 deals together
- [Govtech Fund](https://shizune.co/investors/profile/govtech-fund) — VC Fund, 2 deals together
- [GreatPoint Ventures](https://shizune.co/investors/profile/greatpoint-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [InsurTech Investors in United States](https://shizune.co/investors/insurtech-investors-united-states)
- [InsurTech VC Funds in United States](https://shizune.co/investors/insurtech-vc-funds-united-states)
- [Transportation Investors in South Korea](https://shizune.co/investors/transportation-investors-south-korea)
- [Transportation VC Funds in South Korea](https://shizune.co/investors/transportation-vc-funds-south-korea)
- [Automotive Investors in South Korea](https://shizune.co/investors/automotive-investors-south-korea)
- [Automotive VC Funds in South Korea](https://shizune.co/investors/automotive-vc-funds-south-korea)

## FAQ

### What does Hemi Ventures invest in?

Hemi Ventures invests primarily in Health Care, Artificial Intelligence and Automotive startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Hemi Ventures's check size?

Hemi Ventures typically joins rounds of $500k–$6M at Seed and $2M–$31M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hemi Ventures participates in.

### How do I contact Hemi Ventures?

Public channels for Hemi Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Hemi Ventures?

The team at Hemi Ventures includes Amy Gu (Founder and Managing Partner) and Justin Li (Principal). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co